Results 31 to 40 of about 2,859 (161)

Cerebral infarction caused by systemic sclerosis: a case report

open access: yesJournal of International Medical Research, 2021
Systemic sclerosis, also known as scleroderma, is a rare multisystem autoimmune disease characterized by vascular lesions caused by collagen deposition in the skin and viscera and damage to the endothelium.
Qingqing Wang   +3 more
doaj   +1 more source

Systemic sclerosis with renal crisis and pericardial effusion

open access: yesClinical Case Reports, 2020
Scleroderma renal crisis occurs in 10% of patients with systemic sclerosis carrying a poor prognosis. A kidney biopsy is consistent with thrombotic microangiopathy (TMA) with clinical findings discerning it from other TMAs.
Kalyan Prudhvi   +3 more
doaj   +1 more source

Case Report: Real NPSLE? A patient with systemic sclerosis overlapping systemic lupus erythematosus presenting as epilepsy

open access: yesFrontiers in Immunology, 2023
Neuropsychiatric systemic lupus erythematosus (NPSLE) is the diagnosis that rheumatologists most often need to consider when a patient with lupus presents with neurologic symptoms.
Jialin Zhang   +4 more
doaj   +1 more source

Patterns of renal pathology in Chinese patients with systemic sclerosis undergoing renal biopsy at a tertiary medical center

open access: yesJournal of International Medical Research, 2020
Objective We investigated renal injury characteristics in Chinese patients with systemic sclerosis (SSc) who had undergone renal biopsy. Methods We searched the medical records of patients with SSc who were hospitalized at Peking Union Medical College ...
Xiao-yu Cao   +8 more
doaj   +1 more source

Evaluation of renal damage in a bleomycin-induced murine model of systemic sclerosis [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2023
Objective(s): Systemic sclerosis (SSc) is an autoimmune disease of unknown etiology with a high mortality rate. Renal crisis has been reported as one of the predictors of early mortality in these patients.
Dulce Pérez-Figueroa   +8 more
doaj   +1 more source

Crise renal como manifestação inicial de esclerose sistêmica sine scleroderma Renal crisis as the initial clinical manifestation in systemic sclerosis sine scleroderma

open access: yesRevista Brasileira de Reumatologia, 2004
A esclerose sistêmica (ES) sine scleroderma é uma doença rara, caracterizada pelo acometimento visceral (geralmente gastrintestinal, pulmonar ou vascular periférico) da ES, na ausência da característica fibrose cutânea.
Simone Appenzeller   +3 more
doaj   +1 more source

Kidney complications following COVID-19 vaccination; a review of the literature [PDF]

open access: yesJournal of Nephropharmacology, 2022
Objective: To review the reported cases of kidney injury following vaccination for coronavirus disease 2019 (COVID-19) with a focus on renal pathology.
Shakiba Hassanzadeh   +3 more
doaj   +1 more source

Scleroderma Renal Crisis in Mixed Connective Tissue Disease With Full Renal Recovery Within 3 Months: A Case Report With Expanding Treatment Modalities to Treat Each Clinical Sign as an Independent Entity

open access: yesJournal of Investigative Medicine High Impact Case Reports, 2017
Mixed connective tissue disease (MCTD) is a rheumatologic overlap syndrome that can present with symptoms of systemic lupus erythematous, scleroderma, and polymyositis.
Jordana Cheta MD   +2 more
doaj   +1 more source

Systemic Sclerosis, Reversible Cerebral Vasoconstriction Syndrome, and NeuroMyelitis Optica in a Patient

open access: yesCase Reports in Immunology, 2022
Systemic sclerosis (SSC) is an autoimmune disease of connective tissue and microvasculature mostly caused by autoantibodies. Likewise, neuromyelitis optica (NMO) is a demyelinating disease of the central nervous system correlating with autoantibodies ...
Masoud Etemadifar   +4 more
doaj   +1 more source

Engineered MSC Aggregates with E/N‐Cadherin and IL‐6 Preconditioning for the Treatment of Systemic Sclerosis

open access: yesAdvanced Healthcare Materials, EarlyView.
Engineered 3D‐Cad/IL6‐MSC, developed through synergistic hE/N‐cad‐Fc and IL‐6 preconditioning, show remarkable therapeutic potential for systemic sclerosis. These engineered MSC aggregates reduce pathogenic inflammatory cell infiltration and restore immune balance among CD4+ T‐cell populations, offering a promising approach to optimize MSC based ...
Yue Zhang   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy